160 related articles for article (PubMed ID: 14525764)
1. Association of CBFA2 mutation with decreased platelet PKC-theta and impaired receptor-mediated activation of GPIIb-IIIa and pleckstrin phosphorylation: proteins regulated by CBFA2 play a role in GPIIb-IIIa activation.
Sun L; Mao G; Rao AK
Blood; 2004 Feb; 103(3):948-54. PubMed ID: 14525764
[TBL] [Abstract][Full Text] [Related]
2. Abnormal inside-out signal transduction-dependent activation of glycoprotein IIb-IIIa in a patient with impaired pleckstrin phosphorylation.
Gabbeta J; Yang X; Sun L; McLane MA; Niewiarowski S; Rao AK
Blood; 1996 Feb; 87(4):1368-76. PubMed ID: 8608226
[TBL] [Abstract][Full Text] [Related]
3. Stimulatory antibody-induced activation and selective translocation of protein kinase C isoenzymes in human platelets.
Wang F; Naik UP; Ehrlich YH; Osada S; Ohno S; Kornecki E
Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):401-6. PubMed ID: 7487874
[TBL] [Abstract][Full Text] [Related]
4. Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1.
Jalagadugula G; Mao G; Kaur G; Dhanasekaran DN; Rao AK
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):921-7. PubMed ID: 21252065
[TBL] [Abstract][Full Text] [Related]
5. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine dephosphorylation, but not phosphorylation, of p130Cas is dependent on integrin alpha IIb beta 3-mediated aggregation in platelets: implication of p130Cas involvement in pathways unrelated to cytoskeletal reorganization.
Ohmori T; Yatomi Y; Inoue K; Satoh K; Ozaki Y
Biochemistry; 2000 May; 39(19):5797-807. PubMed ID: 10801330
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein IIb/IIIa inhibition attenuates platelet-activating factor-induced platelet activation by reducing protein kinase C activity.
Hu H; Zhang W; Li N
J Thromb Haemost; 2003 Aug; 1(8):1805-12. PubMed ID: 12911597
[TBL] [Abstract][Full Text] [Related]
8. Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets.
Dorsam RT; Kim S; Jin J; Kunapuli SP
J Biol Chem; 2002 Dec; 277(49):47588-95. PubMed ID: 12297512
[TBL] [Abstract][Full Text] [Related]
9. Decreased platelet expression of myosin regulatory light chain polypeptide (MYL9) and other genes with platelet dysfunction and CBFA2/RUNX1 mutation: insights from platelet expression profiling.
Sun L; Gorospe JR; Hoffman EP; Rao AK
J Thromb Haemost; 2007 Jan; 5(1):146-54. PubMed ID: 17059412
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C-delta activation and tyrosine phosphorylation in platelets.
Moussazadeh M; Haimovich B
FEBS Lett; 1998 Nov; 438(3):225-30. PubMed ID: 9827550
[TBL] [Abstract][Full Text] [Related]
11. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
12. The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin--a phosphoinositide 3-kinase-dependent mechanism.
Kauffenstein G; Bergmeier W; Eckly A; Ohlmann P; Léon C; Cazenave JP; Nieswandt B; Gachet C
FEBS Lett; 2001 Sep; 505(2):281-90. PubMed ID: 11566191
[TBL] [Abstract][Full Text] [Related]
13. Platelet HDL(3) binding sites are not related to integrin alpha(IIb)beta(3) (GPIIb-IIIa).
Pedreño J; de Castellarnau C; Masana L
Atherosclerosis; 2001 Jan; 154(1):23-9. PubMed ID: 11137079
[TBL] [Abstract][Full Text] [Related]
14. A Glanzmann thrombasthenia-like phenotype caused by a defect in inside-out signaling through the integrin alpha(IIb)beta3.
Tomiyama Y; Shiraga M; Kinoshita S; Ambo H; Kurata Y; Matsuzawa Y; Kunicki TJ
Thromb Haemost; 1998 Nov; 80(5):735-42. PubMed ID: 9843164
[TBL] [Abstract][Full Text] [Related]
15. A role for PKCtheta in outside-in alpha(IIb)beta3 signaling.
Soriani A; Moran B; de Virgilio M; Kawakami T; Altman A; Lowell C; Eto K; Shattil SJ
J Thromb Haemost; 2006 Mar; 4(3):648-55. PubMed ID: 16460447
[TBL] [Abstract][Full Text] [Related]
16. Alteration in GPIIb/IIIa Binding of VWD-Associated von Willebrand Factor Variants with C-Terminal Missense Mutations.
König G; Obser T; Marggraf O; Schneppenheim S; Budde U; Schneppenheim R; Brehm MA
Thromb Haemost; 2019 Jul; 119(7):1102-1111. PubMed ID: 31035301
[TBL] [Abstract][Full Text] [Related]
17. Platelet signal transduction pathways: could we organize them into a 'hierarchy'?
Lévy-Toledano S
Haemostasis; 1999 Sep; 29(1):4-15. PubMed ID: 10494030
[TBL] [Abstract][Full Text] [Related]
18. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.
Lanza F; Stierlé A; Fournier D; Morales M; André G; Nurden AT; Cazenave JP
J Clin Invest; 1992 Jun; 89(6):1995-2004. PubMed ID: 1602006
[TBL] [Abstract][Full Text] [Related]
19. Identification of ecto-PKC on surface of human platelets: role in maintenance of latent fibrinogen receptors.
Babinska A; Hogan MV; Sobocki T; Sobocka MB; Ehrlich YH; Kornecki E
Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H2008-19. PubMed ID: 10843900
[TBL] [Abstract][Full Text] [Related]
20. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
